Astellas Pharma Inc. Extends Deal to Sell Pfizer Inc.'s Lipitor in Japan

March 29, 2012 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Pfizer Inc said on Thursday that it has agreed to license Astellas Pharma Inc to make and sell its Lipitor cholesterol drug in Japan to March 2021, extending the term of the previous agreement by five years.

Twitter
LinkedIn
Facebook
Email
Print

Alliances Asia

Pfizer Astellas Pharma US, Inc.